Brief: Truscreen Group Says Coga Trial Validates Superiority Of Truscreen Cervical Cancer Screening Method
05/04/2022 02:02
April 5 (Reuters) - Truscreen Group Ltd TRU.NZ :
* COGA TRIAL VALIDATES SUPERIORITY OF TRUSCREEN CERVICAL
CANCER
SCREENING METHOD
Further company coverage: TRU.NZ
Recent news on Truscreen
See all newsBrief: Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
New Zealand's TruScreen tumbles on discounted placement
Brief: Truscreen Group Says NZ Regco Has Approved A Trading Halt
Brief: Truscreen Announces Opening Of NZ$2.9 Million Capital Raise
Brief: Truscreen Group Sees FY26 Unaudited Loss